The thick heterogeneous (jellylike) placenta: A strong predictor of adverse pregnancy outcome

Prenatal Diagnosis

Volumn 24, Issue 3, 2004, Pages 182-188

  Raio, Luigi ^a   Ghezzi, Fabio ^b   Cromi, Antonella ^b   Nelle, Mathias ^a   Dürig, Peter ^a   Schneider, Henning ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c Department of Obstetrics ^*

Author keywords

Jellylike placenta; Perinatal death; Thick placenta; Ultrasound; Umbilical cord

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; MALE; PERINATAL DEATH; PREDICTION; PRIORITY JOURNAL; SOLUTIO PLACENTAE;

ADULT; FEMALE; GESTATIONAL AGE; HUMANS; PLACENTA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 1842533228     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.828     Document Type: Article

References (26)

1. Bower S, Schuchter K, Campbell S. 1991. Doppler ultrasound screening as part of routine antenatal scanning: prediction of preeclampsia and intrauterine growth restriction. Br J Obstet Gynaecol 98: 871-879.
2. Campbell S, Pearce JM, Hackett G, Cohen-Overbeek T, Hernandez C. 1986. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet Gynecol 68: 649-653.
3. Elchalal U, Ezra Y, Levi Y, et al. 2000. Sonographically thick placenta: a marker for increased perinatal risk-a prospective cross-sectional study. Placenta 21: 268-272.
4. Gonzales AM, Hill DJ, Logan A, Maher PA, Baird A. 1996. Distribution of fibroblast growth factor (FGF)-2 and FGF receptor-1 messenger RNA expression and protein presence in the mid-trimester human fetus. Pediatr Res 39: 375-385.
5. Grannum PAT, Berkowitz RL, Hobbins JC. 1979. The ultrasonic changes in the maturing placenta and their relation to fetal pulmonic maturity. Am J Obstet Gynecol 133: 915-922.
6. Haney AF, Trought WS. 1980. The sonolucent placenta in high-risk obstetrics. Obstet Gynecol 55: 38-41.
7. Haris RD, Cho C, Wells A. 1996. Sonography of the placenta with emphasis on pathological correlation. Semin Ultrasound CT MRI 17: 66-89.
8. Hill DJ, Tevaarwerk GJ, Caddell C, Arany E, Kilkenny D. 1995. Fibroblast growth factor-2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size. J Clin Endocrinol Metab 80: 2626-2632.
9. Hitschold T, Braun S, Weiss E, Berle P, Münterfering H. 1992. A case of discordant flow velocity waveforms in non-anastomosing umbilical arteries: a morphometric analysis. J Matern Fetal Invest 2: 215-219.
10. Jauniaux E. 1992. Placental ultrasonographic measurements: what can we learn and is it worth doing routinely? Ultrasound Obstet Gynecol 2: 241-242.
11. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. 2003. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 162: 115-125.
12. Jauniaux E, Moscoso G, Campbell S, Gibb D, Driver M, Nicolaides KH. 1990. Correlation of ultrasound and pathologic findings of placental anomalies in pregnancies with elevated maternal serum α-fetoprotein. Eur J Obstet Gynecol Reprod 37: 219-230.
13. Jauniaux E, Nicolaides KH. 1996. Placental lakes, absent umbilical artery diastolic flow and poor fetal growth in early pregnancy. Ultrasound Obstet Gynecol 7: 141-144.
14. Jauniaux E, Ramsay B, Campbell S. 1994. Ultrasonographic investigation of placental morphologic characteristics and size during the second trimester of pregnancy. Am J Obstet Gynecol 170: 130-137.
15. Kelly RB, Nyberg DA, Mack LA, Uhrich S. 1989. Sonography of placental abnormalities and oligohydramnios in women with elevated alpha-fetoprotein levels: comparison with control subjects. AJR 153: 815-819.
16. Kofinas AD, Penry M, Swain M, Hatjis CG. 1989. Effect of placental laterality on uterine artery resistance and development of preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 161: 1536-1539.
17. Kurmanovicius J, Wright EM, Royston P, et al. 1999. Fetal ultrasound biometry: abdomen and femur length reference values. Br J Obstet Gynaecol 106: 136-143.
18. Predanic M, Kolli J, Yousefzadeh P, Pennisi J. 1998. Disparate blood flow patterns in parallel umbilical arteries. Obstet Gynecol 91: 757-760.
19. Quinlan RW, Cruz AL, Buhi WC, Martin M. 1982. Changes in placental ultrasonic appearance. I. Incidence of grade III changes in the placenta in correlation to fetal pulmonary maturità. Am J Obstet Gynecol 144: 468-470.
20. Raio L, Ghezzi F, Di Naro E, et al. 2001. In-utero characterization of the blood flow in the Hyrtl anastomosis. Placenta 22: 597-601.
21. Raio L, Ghezzi F, Di Naro E, Gomez R, Brühwiler H. 1998. The clinical significance of antenatal detection of discordant umbilical arteries. Obstet Gynecol 91: 86-91.
22. Thompson MO, Vines SK, Aquilina J, Wathen NC, Harrington K. 2002. Are placental lakes of any clinical significance? Placenta 23: 685-690.
23. Trudinger BJ, Cook CM. 1988. Different umbilical artery flow velocity waveforms in one patient. Obstet Gynecol 71: 1019-1021.
24. Vogel M. 1996. Atlas der morphologischen Plazentadiagnostik, Springer-Verlag: Berlin.
25. Wolff P, Tanaka AM, Chenker E, Cabrera-Crespo J, Raw I, Ho PL. 1996. Purification of fibroblast growth factor-2 from human placenta using tri(n-butyl)phosphate and sodium cholate. Biochimie 78: 190-194.
26. Zalel Y, Lehavi O, Schiff E, Shalmon B, Cohen B, Schulman A. 2002. Shortened fetal long bones: a possible in utero manifestation of placental function. Prenat Diagn 22: 553-557.